|
FY2025
12 months to Nov 1, 2025
|
FY2024
12 months to Nov 2, 2024
|
FY2023
12 months to Oct 28, 2023
|
FY2022
12 months to Oct 29, 2022
|
FY2021
12 months to Oct 30, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Products | |||||
| Services | |||||
| Total revenue | |||||
| Cost of goods sold | |||||
| Products | |||||
| Services | |||||
| Total cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Significant asset impairments and restructuring costs | |||||
| Amortization of intangible assets | |||||
| Acquisition and integration costs | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Interest and other income, net | |||||
| Interest expense | |||||
| Loss on extinguishment and modification of debt | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Basic net income per common share (in dollars per share) | |||||
| Diluted net income per potential common share (in dollars per share) | |||||
| Weighted average basic common shares outstanding (in shares) | |||||
| Weighted average diluted potential common shares outstanding (in shares) |
Loading...